Publications

Publications 2023

  1. Nishiyama K, Nishinakamura H, Takeshima H, Liu YY, Takeuchi C, Hattori N, Takeda H, Yamashita S, Wakabayashi M, Sato K, Obama K and Ushijima T.  Mouse methylation profiles for leukocyte cell types, and estimation of leukocyte fractions in inflamed gastrointestinal DNA samples.  PLoS One, 18: e0290034, 2023.  PMID: 37797047
  2. Arai N, Hattori N, Yamashita S, Liu YY, Ebata T, Takeuchi C, Takeshima H, Fujii S, Kondo H, Mukai H and Ushijima T. HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity. Breast Cancer Res Treat, 201: 317-328, 2023. PMID: 37378696
  3. Hattori N, Liu YY and Ushijima T. DNA Methylation Analysis. Methods Mol Biol, 2691:165-183, 2023. PMID: 37355545
  4. Irie T, Yamada H, Takeuchi C, Liu YY, Charvat H, Shimazu T, Ando T, Maekita T, Abe S, Takamaru H, Kodama M, Murakami K, Sugimoto K, Sakamoto K and Ushijima T. The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa. Gastric Cancer, 26: 667-676, 2023. PMID: 37219707
  5. Shimomura K, Hattori N, Iida N, Muranaka Y, Sato K, Shiraishi Y, Arai Y, Hama N, Shibata T, Narushima D, Kato M, Takamaru H, Okamoto K and Takeda H. Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development.  Nat Commun, 14: 6514, 2023. PMID: 37845228
  6. Yamashiro Y, Ramirez K, Nagayama K, Hattori N, Liu YY, Matsunaga S, Tomita S, Kubota Y and Yanagisawa H. Partial endothelial-to-mesenchymal transition mediated by HIF-induced CD45 in neointima formation upon carotid artery ligation. Cardiovasc Res, 119: 1606-1618, 2023. PMID: 36537041.
  7. Kadono T, Iwasa S, Nagashima K, Oshima K, Yamamoto S, Hirano H, Okita N, Shoji H, Honma Y, Takashima A, Kato K, Ushijima T and Boku N. Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab. Cancer Med, 12: 9322-9331, 2023. PMID: 36789624
  8. Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Yamashita S, Hattori N, Nakamura H, Kawaguchi A, Ushijima T, Sueoka E and Kimura S. Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL. Blood Adv, 7: 1545-1559, 2023. PMID: 36516085
  9. Shimomura A, Yoshida M, Kubo T, Yamashita S, Noguchi E, Nagayama A, Hanamura T, Okazaki M, Mukohara T, Tsuruga A, Tanaka K, Kawamura Y, Higuchi T, Takahashi Y, Kurozumi S, Hayashida T, Ichikawa H, Ushijima T and Suto A. Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast Cancer Res Treat, 197:593-602, 2023. PMID: 36494460
  10. Tanaka S, Umezawa J, Yamaji T, Abe SK, Hamada A, Kobayashi O, Ushijima T and Inoue M. SARS-CoV-2 antibody response to symptoms indicative of COVID-19 in a non-infected population in Japan: A cross-sectional study. Jpn J Infect Dis, 76: 46-54, 2023. PMID: 36184396

MORE

最上部へ